CEOs’ Blind Spots – Middle Years – Asrar Qureshi’s Blog Post 1160

This blog post discusses the mid-tenure blind spot faced by leaders, where they struggle to renew vision and strategy after initial successes. As years progress, complacency sets in, hindering adaptability to changing environments. It emphasizes the importance of reassessing goals, fostering innovation, and maintaining perspective to avoid stagnation and failure.
Share
View Post

Balancing Execution and Innovation in a Fast-Changing World – Asrar Qureshi’s Blog Post 1156

This blog post addresses senior managers in the pharmaceutical industry, emphasizing the critical balance between execution and innovation. It highlights the risks of focusing solely on one, urging leaders to foster environments that nurture both disciplines. The dual operating system model by John P. Kotter is presented as a solution for sustainable growth amidst constant change.
Share
View Post

Technical Expertise vs Customer Experience – Asrar Qureshi’s Blog Post 1150

Asrar Qureshi’s blog post discusses the importance of balancing technical innovation with customer experience in the pharmaceutical industry. Historical examples like Exubera and Vioxx illustrate how neglecting user needs can lead to commercial failure. The future of pharma hinges on prioritizing usability, safety, trust, and accessibility to ensure successful adoption.
Share
View Post

Strategy Meetings in Pharma Industry – Asrar Qureshi’s Blog Post #1126

Asrar Qureshi’s blog post critiques the repetitive nature of annual strategy retreats in the pharma industry, highlighting their ineffectiveness. He proposes transformative approaches, such as framing retreats around key questions, inviting diverse voices, and fostering cross-functional collaboration. The goal is to inspire genuine innovation and actionable strategies for future success.
Share
View Post

Putting Patient Care First – Asrar Qureshi’s Blog Post #1120

In healthcare, patient care must be prioritized above profit-driven motives, as emphasized by Drew Ungerman from McKinsey. Effective systems should focus on improving patient experiences, shifting from “sick care” to “health care.” Innovations should enhance access and reduce disparities, ensuring care is human-centered, dignified, and empathetic.
Share
View Post

Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103

The blog post discusses the stagnation of pharmaceutical marketing due to reliance on outdated strategies, regulatory constraints, and risk aversion. It emphasizes the need for innovation through data-driven personalization, omnichannel engagement, and agile methodologies. A cultural shift toward collaboration and customer-centric approaches is essential for modernization and relevance in a changing landscape.
Share
View Post

Five AI Trends to Watch in 2025 (and Beyond) – Asrar Qureshi’s Blog Post #1061

Asrar Qureshi’s blog outlines five significant AI trends expected by 2025. These include the democratization of coding through AI tools, the creation of high-quality AI-generated films, the rise of autonomous AI agents, improving affordability and performance of AI technologies, and an ongoing AI development surge amidst limited government regulation.
Share
View Post

Leaders Can Be Vulnerable – Asrar Qureshi’s Blog Post #1016

Asrar Qureshi’s blog post emphasizes the importance of vulnerability in leadership, highlighting its role in building trust, fostering innovation, and encouraging authenticity within teams. By embracing vulnerability, leaders can enhance engagement and resilience, creating a supportive environment that nurtures growth. This approach, when balanced, strengthens leadership rather than diminishing it.
Share